Skip to main content

Advertisement

Figure 1 | BMC Cancer

Figure 1

From: Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma

Figure 1

Immunohistochemical stainings of H3K27me3 in human esophageal tissues. (A) A normal esophageal mucosa (case 13) showed low expression of H3K27me3 protein, in which less than 50% of normal esophageal squamous cells showed positive staining of H3K27me3 in nuclei (200×). (B) An ESCC case (case 21) demonstrated low expression of H3K27me3, in which less than 50% of squamous cell carcinoma cells showed positive staining of H3K27me3 protein in nuclei (200×). (C) High expression of H3K27me3 was observed in an ESCC (case 39), where more than 70% carcinoma cells demonstrated positive staining of H3K27me3 in nuclei (200×). (D) A primary ESCC (case 52) was observed high expression of H3K27me3, where more than 90% carcinoma cells showed positive staining of H3K27me3 protein in nuclei (200×). (E) Another ESCC (case 7) was observed high expression of EZH2, where more than 90% of carcinoma cells showed positive staining of EZH2 protein in nuclei (400×). (F) High expression of H3K27me3 (more than 80% of carcinoma cells showed positive expression of H3K27me3) was observed in the same ESCC case 7 (400×). (G) For the 53 ESCC cases with high EZH2 expression, an average of 55.0% of the ESCC cells stained positive with H3K27me3 antibody, a percentage of cancer cells that was significantly larger than that (43.3%) in the remaining 45 cancers with a low expression of EZH2 (P = 0.036, independent sample t test).

Back to article page